Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer

BACKGROUND: Regulatory T (Treg) cells play a negative role in anti-tumor immunity against triple-negative breast cancer, so it is of great significance to find the potential therapeutic target of Treg cells. METHODS: First, Annexin A1 (ANXA1) expression and survival of patients with breast cancer we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Fang, Zhang, Peng, Fu, Yipeng, Chen, Hongliang, Zhang, Mingdi, Huang, Qianru, Li, Dan, Li, Bin, Wu, Kejin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204868/
https://www.ncbi.nlm.nih.gov/pubmed/32300050
http://dx.doi.org/10.1136/jitc-2019-000169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204868/
https://www.ncbi.nlm.nih.gov/pubmed/32300050
http://dx.doi.org/10.1136/jitc-2019-000169

Ejemplares similares